OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Correction to: Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders	478
Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder	361
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1	306
Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation	251
We’re all in this together: a rejoinder to Masud Husain’s (rant) editorial	248
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures	240
The RAB3A hot spot variant R83W causes spasticity as part of the ataxia-spasticity spectrum	225
Deep brain stimulation: a tale of two targets … and closing the loop	218
Reply: Is postural tachycardia syndrome a psychogenic disorder?; Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome; Patients with POTS fear that data o	197
Thalamic stereo EEG: a clinically justified extension of hypothesis-driven intracranial exploration	192
Genetically identical twin-pair difference models support the amyloid cascade hypothesis	176
In vivo self-assembled siRNAs ameliorate neurological pathology in TDP-43-associated neurodegenerative disease	175
Maternal microbiome-derived propionate regulates offspring myelination via histone lactylation	175
Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism	167
Lesion correlates of impaired acoustic-phonetic perception after unilateral left hemisphere stroke	155
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing	147
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models	145
Apathy, effort-based decisions and brain integrity in Alzheimer's and Parkinson's diseases	144
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults	142
Thalamostriatal disconnection underpins long-term seizure freedom in frontal lobe epilepsy surgery	142
Source-sink connectivity: a novel interictal EEG marker for seizure localization	134
Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations	129
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum	124
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes	124
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression	121

Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine	117
De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features	116
The use of optical coherence tomography in neurology: a review	116
Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins	116
Dopamine and the dynamics of subthalamic and leg muscle activities in parkinsonian stepping	115
Global network and local vulnerabilities underlie brain atrophy across Parkinson’s disease stages	112
The significance of electrophysiological recordings from the bed nucleus of the stria terminalis in humans	108
Brain repair mechanisms after cell therapy for stroke	108
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease	104
The vascular contribution of apolipoprotein E to Alzheimer’s disease	102
Speech and language markers of neurodegeneration: a call for global equity	99
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development	99
From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis	98
Subthalamic spatio-spectral-connectivity of psychiatric symptoms in Parkinson’s disease	97
Dysfunction of the magnocellular subdivision of the visual thalamus in developmental dyslexia	95
‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy	94
The inferior fronto-occipital fasciculus: bridging phylogeny, ontogeny and functional anatomy	92
Correction to: New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy	91
Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability	85
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease	85
Demystifying interictal discharges and seizure initiation in focal epilepsy	85
Natural experiment on neuroinflammatory disease incidence and infection links pre- and post-COVID-19	84
Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy	84
Routes of precursors’ migration in remyelination	84
New mechanistic insights into hereditary spastic paraplegias	82
Extra-cranial cholinergic lesions in dementia with Lewy bodies	82
Evolutionary perspectives on mRNA signatures of neurodegeneration-related brain remodelling	81
That which we call cortisol awakening response, by any other word would smell as sweet	81
Functional network reorganization precedes apathy in Parkinson’s disease: a neural marker of risk?	81
Deciphering the impact of coding and non-coding SCN1A gene variants on RNA splicing	81
Preclinical type 2 diabetes mellitus subtypes: new insights into diabetes, depression and dementia	81
Cross-seeding by prion protein inactivates TDP-43	78
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration	77
From phenomena to phrasing: rethinking seizure classification through history	76
Normalization of network activity in an epilepsy model with a constitutively active GABBR2 variant	76
Distinct contribution of spinal neuropeptide Y and NPY1R neurons to morphine analgesia	75
Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis	75
The low dimensionality of post-stroke cognitive deficits: it’s the lesion anatomy!	75
Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1–ADAM22/23 pathway	75
Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit	75
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults	75
Cortical cerebral microinfarcts spark cognitive decline	73
Integrative miRNA–mRNA profiling of human epidermis: unique signature of SCN9A painful neuropathy	72
Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders	72
Loss-of-function variants inMYCBP2cause neurobehavioural phenotypes and corpus callosum defects	69
Multimodal mapping of regional brain vulnerability to focal cortical dysplasia	69
Biallelic null variants in PNPLA8 cause microcephaly by reducing the number of basal radial glia	69
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence	69
GGC repeat expansions in NOTCH2NLC cause uN2CpolyG cerebral amyloid angiopathy	69